Chaicharn Deerochanawong Selected Research

Regimen B

11/2014	Comparison effect of loading calcitriol and titrating calcitriol treatment to control hypocalcemia after parathyroidectomy in chronic kidney disease: randomized control trial, open labeled.
3/2011	Role of loading calcitriol to control hypocalcemia after parathyroidectomy in chronic kidney disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Chaicharn Deerochanawong Research Topics

Disease

23	Type 2 Diabetes Mellitus (MODY) 03/2022 - 02/2002
6	Cardiovascular Diseases (Cardiovascular Disease) 07/2021 - 03/2007
6	Body Weight (Weight, Body) 01/2021 - 09/2016
4	Diabetes Mellitus 08/2022 - 02/2002
4	Chronic Renal Insufficiency 01/2022 - 03/2011
4	Hypertension (High Blood Pressure) 02/2016 - 08/2006
4	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 02/2003 - 02/2002
3	Dyslipidemias (Dyslipidemia) 03/2022 - 01/2007
3	Gestational Diabetes (Gestational Diabetes Mellitus) 03/2022 - 11/2018
3	Diabetic Retinopathy (Retinopathy, Diabetic) 04/2021 - 08/2006
3	Prediabetic State (Prediabetes) 02/2021 - 03/2013
3	Heart Failure 02/2021 - 11/2019
3	Disease Progression 01/2021 - 02/2012
3	Overweight 01/2020 - 03/2007
3	Weight Gain 01/2020 - 01/2019
3	Hypoglycemia (Reactive Hypoglycemia) 01/2019 - 12/2010
3	Stroke (Strokes) 01/2019 - 08/2006
3	Hyperglycemia 01/2019 - 11/2018
3	Foot Ulcer 02/2016 - 08/2006
3	Diabetic Nephropathies (Diabetic Nephropathy) 03/2014 - 08/2006
2	Albuminuria 01/2021 - 08/2006
2	Kidney Diseases (Kidney Disease) 01/2021 - 03/2014
2	Myocardial Infarction 01/2019 - 08/2006
2	Diabetes Complications 01/2018 - 08/2006
2	Ulcer 02/2016 - 08/2006
2	Hypocalcemia 11/2014 - 03/2011
1	Insulin Resistance 03/2022
1	Essential Hypertension 01/2022
1	Pain (Aches) 04/2021
1	Chronic Kidney Failure (Chronic Renal Failure) 01/2021
1	Abdominal Obesity 01/2020
1	Neoplasms (Cancer) 01/2020
1	Thyroid Neoplasms (Thyroid Cancer) 01/2020
1	Weight Loss (Weight Reduction) 12/2019
1	Obesity 01/2019
1	Vitamin D Deficiency 02/2017
1	Hypophosphatemia 02/2016
1	Congenital Abnormalities (Deformity) 02/2016
1	Hypercalcemia (Milk Alkali Syndrome) 02/2016
1	Hypesthesia (Numbness) 02/2016
1	Diabetic Foot 02/2016
1	Primary Hyperparathyroidism 02/2016
1	Ketosis 03/2013
1	Langerhans-Cell Histiocytosis (Histiocytosis, Langerhans Cell) 03/2011
1	Adenoma (Adenomas) 03/2011
1	Hyperplasia 03/2011
1	Hyperparathyroidism 03/2011

Drug/Important Bio-Agent (IBA)

13	Insulin (Novolin)FDA Link 08/2022 - 03/2002
11	Glucose (Dextrose)FDA LinkGeneric 03/2022 - 08/2006
4	LipidsIBA 03/2022 - 08/2006
4	oxidized low density lipoproteinIBA 03/2022 - 01/2007
4	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 03/2014 - 06/2008
3	LDL CholesterolIBA 03/2022 - 10/2011
3	Sodium-Glucose Transporter 2 InhibitorsIBA 01/2021 - 11/2019
3	SodiumIBA 01/2021 - 11/2019
3	Metformin (Glucophage)FDA LinkGeneric 01/2020 - 03/2007
3	CreatinineIBA 03/2010 - 08/2006
2	CholesterolIBA 03/2022 - 07/2008
2	dapagliflozinIBA 01/2022 - 07/2021
2	Sodium-Glucose Transport ProteinsIBA 02/2021 - 12/2019
2	Glucagon-Like Peptide 1 (GLP 1)IBA 12/2019 - 01/2019
2	semaglutideIBA 12/2019 - 01/2019
2	Blood Glucose (Blood Sugar)IBA 11/2019 - 03/2013
2	Hypoglycemic Agents (Hypoglycemics)IBA 01/2019 - 08/2006
2	Parathyroid Hormone (Parathormone)IBA 02/2016 - 11/2014
2	CalciumIBA 11/2014 - 03/2011
2	Calcitriol (Calcijex)FDA LinkGeneric 11/2014 - 03/2011
2	Calcium Gluconate (CBG)IBA 11/2014 - 03/2011
2	HDL CholesterolIBA 03/2014 - 02/2009
2	Antihypertensive Agents (Antihypertensives)IBA 08/2006 - 08/2006
1	azilsartan medoxomilIBA 01/2022
1	Opioid Analgesics (Opioids)IBA 04/2021
1	Antidepressive Agents (Antidepressants)IBA 04/2021
1	Anticonvulsants (Antiepileptic Drugs)IBA 04/2021
1	Analgesics (Analgesic Drugs)IBA 04/2021
1	LC15-0444IBA 01/2020
1	IodineIBA 01/2020
1	ThiazolidinedionesIBA 01/2020
1	empagliflozinIBA 12/2019
1	Sitagliptin Phosphate (Januvia)FDA Link 01/2019
1	Liraglutide FDA Link 01/2019
1	Biphasic InsulinsIBA 01/2018
1	biphasic human insulin 30IBA 01/2018
1	insulin aspart protamine drug combination 30:70 insulin aspartIBA 01/2018
1	Vitamin D FDA LinkGeneric 02/2017
1	glimepiride (Amarel)FDA LinkGeneric 09/2016
1	CanagliflozinIBA 09/2016
1	Triglycerides (Triacylglycerol)IBA 03/2014
1	Hemoglobins (Hemoglobin)IBA 03/2014
1	SYBR Green IIBA 03/2011
1	lithocholyl-N-hydroxysuccinimideIBA 03/2011

Therapy/Procedure

7	Glycemic Control 04/2021 - 08/2006
7	Therapeutics 04/2021 - 07/2008
4	Drug Therapy (Chemotherapy) 04/2021 - 03/2007
3	Surgical Amputation (Amputations) 02/2016 - 08/2006
2	Parathyroidectomy 11/2014 - 03/2011
2	Regimen B 11/2014 - 03/2011
1	Continuity of Patient Care 01/2020
1	Secondary Prevention 11/2019
1	Length of Stay 11/2014